Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring.

Wenningmann N, Knapp M, Ande A, Vaidya TR, Ait-Oudhia S.

Mol Pharmacol. 2019 Aug;96(2):219-232. doi: 10.1124/mol.119.115725. Epub 2019 Jun 4.

PMID:
31164387
2.

Combining Multiscale Experimental and Computational Systems Pharmacological Approaches to Overcome Resistance to HER2-targeted Therapy in Breast Cancer.

Vaidya TR, Ande A, Ait-Oudhia S.

J Pharmacol Exp Ther. 2019 Jun;369(3):531-545. doi: 10.1124/jpet.118.255752. Epub 2019 Mar 21.

PMID:
30898866
3.

Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer.

Franco YL, Vaidya TR, Ait-Oudhia S.

Breast Cancer (Dove Med Press). 2018 Sep 11;10:131-141. doi: 10.2147/BCTT.S170239. eCollection 2018. Review.

4.

Utility of a Novel Three-Dimensional and Dynamic (3DD) Cell Culture System for PK/PD Studies: Evaluation of a Triple Combination Therapy at Overcoming Anti-HER2 Treatment Resistance in Breast Cancer.

Ande A, Vaidya TR, Tran BN, Vicchiarelli M, Brown AN, Ait-Oudhia S.

Front Pharmacol. 2018 May 1;9:403. doi: 10.3389/fphar.2018.00403. eCollection 2018.

Supplemental Content

Loading ...
Support Center